Results

Total Results: 1,653 records

Showing results for "described".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
    May 09, 2016 - DPN is usually described as glove-stocking distribution of numbness, sensory loss, paresthesia (abnormal … ulcerations.14 Although DPN is not an outcome in studies addressing these comorbid conditions, they may be described … the Review Inclusion and exclusion criteria are provided in Table A, based on the PICOTS framework described … As described in Section A. we will assess systematic reviews with ROBIS and, where possible, will use
  2. S149 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
    October 01, 2007 - Using the algorithm described in the methods, we estimated propensity scores for each treatment regimen … As described in the algorithm, the expected outcome (charges) for each strata was estimated by linear … As described in step 3), the transitional probabilities in columns 5 and 6 were estimated by proportional … As described in step 4), the expected outcome (in this case, charges) for each strata was estimated by
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
    January 30, 2012 - Inclusion/Exclusion of Studies in the Review We will apply the inclusion and exclusion criteria described … Data needed to assess quality and applicability, as described in the Methods Guide,25 will also be abstracted … The strength of evidence will be assessed by using the approach described in AHRQ’s Methods Guide.25,28 … Assessing Applicability We will assess applicability across our key questions using the method described
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
    November 01, 2014 - 2005 by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) described … independently reviewed each full-text article for inclusion or exclusion based on the eligibility criteria described … Further, methods were not clearly described. … principles and clinical trial efficacy data.1 Nevertheless, the effectiveness of the dosing strategies described
  5. effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
    January 01, 2015 - Peer Reviewer #3 Results Are the characteristics of the studies clearly described? Yes. … In the ‘Summary’ column of these tables effects are described as small, medium/moderate, and large but … We described these studies in the text. … We made a note of this in Table 2, where the drugs are first described. … DPP4 inhibitors are misleadingly described as less effective.
  6. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
    January 12, 2022 - Effectiveness Reviews.32 Studies will be rated as being “low,” “moderate,” or “high” risk of bias as described … initially assessed by one researcher for each clinical outcome (see PICOTS) by using the approach described … noted as “no evidence” The strength of the evidence may be downgraded based on the limitations described … existence of plausible unmeasured confounders), if there are no downgrades on the primary domains, as described
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
    December 09, 2009 - The steps that we will take to accomplish the literature review are described below. … independently reviewed by two members of the team for inclusion or exclusion based on the eligibility criteria described
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: November 9, 2011 Evidence-based Practice Center Systematic Review Protocol Project Title: Critical Analysis of the Evidence for Patient Safety Practices I. Background and Objectives fo…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
    September 01, 2014 - Strength of Evidence Grading We used the EPC system for grading evidence on diagnostic tests as described … concern about reporting bias, the finding was precise, and one of the three types of conclusions described … Settings of care were to be described, and if data permitted, subgroups of studies by setting were … We included the remaining 130 publications, which described 123 unique studies/reviews (seven publications … Imaging Techniques for Diagnosis and/ or Staging We included a total of 78 studies for this KQ: 50 described
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - For studies where the specific randomization method is unclear, but the study is described as “randomized … Is the study described as randomized? 2. … Is the study described as non-randomized? 2. Are there more than 250 subjects? 4. … efforts will be made to obtain it and the HR will be calculated from published reports, using methods described … or in both arms not attributable to lack of ascertainment, pooling will be performed using methods described
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_disposition-comments.pdf
    August 21, 2013 - On page 7, line 4-5, FACT is correctly described as involving modification of the ACT model. … Methods: Scope and parameters of this report are well- described and justified. … Introduction: The Key questions are clearly described. … Results Results: I thought the methodology generally and inclusion/exclusion criteria were very well described … Discussion/ Conclusion: The implications of the findings are well stated, and the limitations well described
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
    March 25, 2012 - diminished sexual function and vaginal dryness are also common.7-9 A natural history of symptoms can be described … Current evidence supporting the safety and effectiveness of compounded hormone therapies is generally described … therapy—published as a scientific statement.29 Efforts to systematically review and synthesize the literature were described … colorectal, or ovarian cancer; similar study types, duration, and size criteria will be applied as described … For the more quantitative approach, we will adapt the method described by Thompson et al.46 E.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
    December 20, 2011 - Interventions Specific psychological interventions that have been studied for the treatment of PTSD are described … The KQs are displayed within the PICOS context described in the previous section. … Appropriateness will be determined by the same methods described above. Table 4. … independently review each full-text article for inclusion or exclusion based on the eligibility criteria described … As described above, all results will be tracked in an EndNote database.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
    March 29, 2011 - We anticipate that the evidence garnered from the literature search described above will consist of … Summary of Protocol Amendments This amendment is to clarify methods described in the protocol for the … March 29, 2011 KQ 1a & 1b We will begin with a review of existing reviews, using the methods described … We anticipate that the evidence garnered from the literature search described above will consist of small … Summary of Protocol Amendments This amendment is to clarify methods described in the protocol for the
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
    May 01, 2015 - The purpose of this document is well described in the preface materials. … The purpose of these sections is now described more in the methods and we have changed the titles for … To the extent that certain functionalities exist in both settings, we have described them, but with … The opportunities for clinical decision support are well described. Thank you for your comment. … Peer Reviewer #7 Findings This is well described and critical for children.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
    October 30, 2019 - An additional problem is that this criterion is often not interpreted as described here: the wording … In some places there was inconsistency in the way the results were described. … Reviewer #3 Results All types of observational studies were often combined into a single category and described … instruments focus on stroke rates at different scores but don’t seem to report the c-statistic which is described … The results aren’t really described in a parallel fashion to KQ 1, e.g. the summary bullets don’t describe
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
    February 07, 2018 - Although these latter strategies are less rigorous, they will be considered for inclusion and described … of non-English language articles will be reviewed at the abstract stage consistent with the process described … The appropriateness of those studies will be determined using the methods described above.
  18. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
    October 12, 2015 - the context of the population, interventions, comparators, outcomes, timings, and settings (PICOTS) described … Data necessary for assessing quality and applicability, as described in the Methods Guide,57 will also … The strength of evidence will be assessed using the approach described in the AHRQ’s Methods Guide.57,63 … Key aspects of previous reviews to be described include number and types of studies included, strength … Assessing Applicability We will assess applicability across our key questions using the method described
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
    August 09, 2013 - liver.14 MRI can also be used as an adjunct to CT to better detect extrahepatic disease.17,18 As described … encasement, or any distant metastases • A “borderline” resectable tumor fits neither of the two categories described … For statistical analyses comparing the accuracy of two imaging tests, we will use the EPC methods described … Comparisons and Outcomes We will use the EPC system for grading evidence on diagnostic tests as described … Settings of care will be described, and if data permit, subgroups of studies based on setting will be
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-frameworks.ppt
    June 01, 2012 - comparator, outcomes, timing, and setting) typology, analytic frameworks, and decision trees will be described … Principle 2: Develop an Analytic Framework (1 of 2) The second principle described to address challenges … Most organizational frameworks have categories that line up with the analytic framework described in … Cases Illustrating the Five Principles To illustrate the five principles described, three case examples … Sample Replacement Test Project: FFDM Versus SFM (2 of 4) After using the principles described in this

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: